4 Between GLP-1s ability to boost insulin and control glucagon for healthy blood sugar levels and to help slow digestion and help you feel full faster, the buzz around this hormone makes a lot of sense
Not only did primary analysis reveal reduced death from cardiovascular causes and non-fatal myocardial infarction overall, but prespecified secondary analysis also showed that, among patients with atherosclerotic disease and heart failure, there were reduced composite heart failure hospitalizations and cardiovascular deaths among patients taking semaglutide
Maintenance of Certification in Anesthesiology and MOCA are registered certification marks of the American Board of Anesthesiology American Board of Internal Medicine (ABIM) Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Medical Knowledge MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
January 22, 2024
Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity since the US Food & Drug Administration first approved semaglutide (brand name Ozempic/Wegovy) for weight loss in 2021
doi: 10.1016/S0140-6736(18)32261-X 13 GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet al
